Reports & Presentations
Subsidiary Financials 2024 -25
- Glenmark Healthcare Limited
- Glenmark Pharmaceuticals FZE
- Glenmark Pharmaceuticals (Australia) Pty Ltd
- GLENMARK PHARMACEUTICALS ECUADOR S.A.
- GLENMARK PHARMACEUTICAL SPA
- Glenmark Pharmaceuticals Egypt S.A.E.
- Glenmark Philippines Inc.
- Glenmark Pharmaceutical Colombia SAS
- Glenmark Dominicana SRL
- Glenmark Pharmaceuticals Kenya Ltd
- Glenmark Pharmaceuticals Mexico, S.A. DE C.V.
- Glenmark Pharmaceuticals Singapore Pte. Ltd.
- Glenmark Pharmaceuticals Peru SAC
- Glenmark Pharmaceuticals (Thailand) Co. Ltd
- Glenmark Uruguay S.A.
- Glenmark Pharmaceuticals Malaysia Sdn Bhd
- Glenmark Pharmaceuticals (Nigeria) Ltd
- Glenmark Pharmaceuticals Europe Ltd
- Glenmark Specialty SA
- Glenmark Pharmaceuticals B.V.
- Glenmark Farmaceutica SLU
- Sintesy Pharma SRL
- Glenmark South Africa Proprietary Limited
- Glenmark Pharmaceuticals South Africa Proprietary Limited
